Cutia Therapeutics (HK:2487) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Cutia Therapeutics’ CEO, Ms. Zhang Lele, has further increased her stake in the company by purchasing an additional 5,000 shares, reflecting her strong confidence in its future growth. This brings her total recent acquisitions to 33,000 shares, amounting to approximately HK$393,212. Her actions underscore a positive outlook for the company’s market potential and business prospects.
For further insights into HK:2487 stock, check out TipRanks’ Stock Analysis page.